Mablink Bioscience – Strategic-Technological Analysis

Mablink Bioscience is a Lyon-based (France) biotechnology company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment[1][2]. It uses a proprietary hydrophilic “PSARlink” linker platform to create homogeneous, stable ADCs with high drug-to-antibody ratios[1]. This makes Mablink a deep-tech startup in precision oncology. Althou…